VECTRON BIOSOLUTIONS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: TE
Trond Erik Vee Aune1976
Chairman of the board: CC
Carl-Åke Carlsson1963
Years since formation: 16 years; since Jul 1, 2008
Type: Limited company
VAT registered: Yes
Number of employees: 7

Ownership

Number of shares and share classes: 3,625,284; 2 share classes
Total number of shareholders: 33; 15 companies, 18 persons

Financials

Total operating income 2023: 5,423,673; NOK
Annual total result 2023: -12,551,288; NOK
Total equity 2023: 22,298,359; NOK

Last update: Oct 14, 2024

Management

Management / administration

Name	Role	Shares
TE Trond Erik Vee Aune 1976	Managing Director/CEO	2.4 % directly

Board

Name	Role	Shares
CC Carl-Åke Carlsson 1963	Chairman	-
TE Trond Erik Vee Aune 1976	Board Member	2.4 % directly
TE Tom Edward Pike 1960	Board Member	-
JE Jan Erik Foss 1970	Board Member	-
RV Reinhard Vogt 1955	Board Member	-

Others

Name	Role	Shares
B BDO AS	Auditor	-
S SPAREBANK 1 REGNSKAPSHUSET SMN AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
JT Jan Trygve Håbrekke 1963	-	4.97 % indirectly
KB Kai Bogen 1953	-	3.46 % indirectly
TE Trond Erik Vee Aune 1976	Managing Director/CEO, Board Member	2.4 % directly
AS Alexander Samsonsen 1975	-	1.83 % directly
MV Marit Valla 1976	-	1.41 % directly
ST Solveig Tryggestad 1947	-	1.01 % indirectly
SJ Svein Jon Tryggestad 1946	-	1.01 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
D Dynamk Capital Llc	A-shares	808,149	22.29 %
L LEIV EIRIKSSON NYSKAPING AS	Ordinary shares	703,723	19.41 %
E EIDCO AS	Ordinary shares	522,133	14.4 %
T T3s Technologies Inc	Ordinary shares	383,953	10.59 %
S SPAREBANK 1 SMN INVEST AS	Ordinary shares	220,000	6.07 %
I INVESTITUDE AS	Ordinary shares	180,000	4.97 %
S SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING	Ordinary shares	100,397	2.77 %
H HELIFT AS	Ordinary shares	100,000	2.76 %
TE Trond Erik Vee Aune 1976	Ordinary shares	85,320	2.35 %
B BAF HOLDING AS	Ordinary shares	65,000	1.79 %
AS Alexander Samsonsen 1975	Ordinary shares	58,000	1.6 %
E EIDCO AS	A-shares	55,000	1.52 %
MV Marit Valla 1976	Ordinary shares	51,035	1.41 %
CC Competence Ab Core	Ordinary shares	49,014	1.35 %
M MUST INVEST AS	Ordinary shares	41,667	1.15 %
L LEIV EIRIKSSON NYSKAPING AS	A-shares	39,412	1.09 %
TV Tone Valla 1974	Ordinary shares	30,035	0.83 %
T TURTLE INVEST AS	Ordinary shares	28,300	0.78 %
C CÅC INVEST AS	Ordinary shares	25,067	0.69 %
V VECTRON BIOSOLUTIONS AS	Ordinary shares	20,905	0.58 %
T TURTLE INVEST AS	A-shares	9,000	0.25 %
AS Alexander Samsonsen 1975	A-shares	8,500	0.23 %
TE Tom Edward Pike 1960	Ordinary shares	6,667	0.18 %
BV Birgit Valla 1977	Ordinary shares	5,500	0.15 %
KV Kristin Valla 1975	Ordinary shares	5,500	0.15 %
JB Janet Martha Blatny 1966	Ordinary shares	4,433	0.12 %
B BAF HOLDING AS	A-shares	3,500	0.1 %
KP Karunankarab Ponniah	Ordinary shares	3,483	0.1 %
IB Ingrid Bakke 1963	Ordinary shares	3,333	0.09 %
RL Rahmi Lale 1977	Ordinary shares	3,333	0.09 %
LB Laila Berg 1973	Ordinary shares	3,000	0.08 %
TE Trond Erik Vee Aune 1976	A-shares	1,792	0.05 %
MM Morteza Shojaei Moghadam 1982	Ordinary shares	133	< 0.01 %

Shares owned by the VECTRON BIOSOLUTIONS AS

Name	Share class	Number of shares	Share
V VECTRON BIOSOLUTIONS AS	Ordinary shares	20,905	0.58 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	5,423,673	7,568,873	7,309,200
Annual Total Result	-12,551,288	-7,976,851	-5,482,193
Total assets	27,038,284	39,927,953	45,063,220
Total liabilities	4,739,925	5,082,297	5,521,969
Total equity	22,298,359	34,845,656	39,541,252

P&L

Year	2023	2022	2021
Total operating income	5,423,673	7,568,873	7,309,200
Total operating costs	17,132,337	15,636,187	13,149,468
Operating result	-11,708,664	-8,067,314	-5,840,267
Financial income/costs	-2,066	90,463	358,075
Profit before tax	-11,710,730	-7,976,851	-5,482,193
Total tax & extraordinary income/cost	840,558	0	0
Annual Total Result	-12,551,288	-7,976,851	-5,482,193

Balance overview

Year	2023	2022	2021
Total fixed assets	18,903,568	21,930,400	23,166,005
Total current assets	8,134,716	17,997,553	21,897,216
Total assets	27,038,284	39,927,953	45,063,220
Short term debt	2,806,613	2,748,977	2,788,641
Long term debt	1,933,312	2,333,320	2,733,328
Total liabilities	4,739,925	5,082,297	5,521,969
Contributed capital	22,298,359	34,845,656	39,541,252
Retained earnings	0	0	0
Total equity	22,298,359	34,845,656	39,541,252
Total equity and liabilities	27,038,284	39,927,953	45,063,220

VECTRON BIOSOLUTIONS AS992 779 837